Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen Hu

Showing results (1001-1010 of 1,174) with videos related to

Pageof 118
Sort By:
BMC Cancer|April 19, 2024
The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II studyTongzhen Xu, Lingling Feng, Wenjue Zhang, et al.
Advances in Radiation Oncology|December 6, 2017
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408R Charles Nichols, Chen Hu, Jean-Paul Bahary, et al.
Nature Communications|March 18, 2022
Dual-gated single-molecule field-effect transistors beyond Moore's lawLinan Meng, Na Xin, Chen Hu, et al.
Cancer Biomarkers : Section a of Disease Markers|December 28, 2017
Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathwayBin Zhao, Yu-Lin Lu, Yong Yang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2022
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple SclerosisEleni S Vasileiou, Chen Hu, Charles N Bernstein, et al.
Future Oncology (London, England)|November 29, 2023
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocolJia-Ying Li, Shu-Nan Qi, Chen Hu, et al.
European Journal of Pharmacology|February 13, 2021
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)Tingting Lu, Jiangyan Cao, Fengming Zou, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2025
Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia modelBai-Ling Zhang, Hui Li, Wei-Xiao Wang, et al.
Scientific Reports|June 10, 2017
Prenatal chromium exposure and risk of preterm birth: a cohort study in Hubei, ChinaXinyun Pan, Jie Hu, Wei Xia, et al.
AIDS and Behavior|May 20, 2009
The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site studyDenise A Hien, Aimee N C Campbell, Therese Killeen, et al.
Pageof 118

Showing results (1001-1010 of 1,174) with videos related to

Sort By:
Pageof 118
BMC Cancer|April 19, 2024
The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II studyTongzhen Xu, Lingling Feng, Wenjue Zhang, et al.
Advances in Radiation Oncology|December 6, 2017
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408R Charles Nichols, Chen Hu, Jean-Paul Bahary, et al.
Nature Communications|March 18, 2022
Dual-gated single-molecule field-effect transistors beyond Moore's lawLinan Meng, Na Xin, Chen Hu, et al.
Cancer Biomarkers : Section a of Disease Markers|December 28, 2017
Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathwayBin Zhao, Yu-Lin Lu, Yong Yang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2022
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple SclerosisEleni S Vasileiou, Chen Hu, Charles N Bernstein, et al.
Future Oncology (London, England)|November 29, 2023
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocolJia-Ying Li, Shu-Nan Qi, Chen Hu, et al.
European Journal of Pharmacology|February 13, 2021
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)Tingting Lu, Jiangyan Cao, Fengming Zou, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2025
Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia modelBai-Ling Zhang, Hui Li, Wei-Xiao Wang, et al.
Scientific Reports|June 10, 2017
Prenatal chromium exposure and risk of preterm birth: a cohort study in Hubei, ChinaXinyun Pan, Jie Hu, Wei Xia, et al.
AIDS and Behavior|May 20, 2009
The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site studyDenise A Hien, Aimee N C Campbell, Therese Killeen, et al.
Pageof 118